Therefore, human anti-tetanus immunoglobulin (TIG) is indicated for all persons at risk of contracting tetanus after being wounded if they are not (fully) vaccinated or are immuno-compromised [ 4].
Because of the high attack rate of brucellosis among exposed workers, the unpredictable and often chronic course of the disease, and the difficulties in eradicating the organism once a symptomatic infection has been established, postexposure prophylaxis is probably indicated for all persons after an obvious exposure to living brucellae (26).
Chemoprophylaxis is indicated for persons who have close contact with someone with invasive meningococcal infection (9 ), but there is uncertainty regarding the treatment of asymptomatic persons who have contact with someone with N. meningitidis urethritis.
In the United States, the quadrivalent conjugated meningococcal vaccine is recommended for all persons 11 18 years of age and is indicated for persons 2 55 years of age who are at increased risk for IMD (10, 11 ).
The 4CMenB vaccine is indicated for persons 2 mo of age or older.
Prophylaxis is indicated for persons exposed to an airspace contaminated with aerosolized B. anthracis.
The APSA is indicated for persons who are capable of introspection and are aware of cognitive failures and mishaps which they are able to remember when answering the questionnaire.
Although respirators were indicated for persons working inside the quarantine barn, construction of the barn allowed unfiltered air to flow between the barn and the adjacent 2-story administrative support areas where respirators were not worn.
Recently, a vaccine, 4CMenB (Bexsero®), containing three recombinant proteins, and outer membrane vesicles (OMV) derived from a serogroup B meningococcal strain (MenB) has been licensed in Europe and Australia and is indicated for persons aged 2 mo or older.
Hepatitis B vaccine is indicated for persons planning long-term travel (generally >6 weeks) to areas of high hepatitis B prevalence or who anticipate parenteral exposure (dental procedures, needle exposure, blood products) or sexual exposure to hepatitis B virus.
Providers ordering only the Aventis Pasteur formulation, indicated for persons aged 6 months and older, may have gotten less vaccine than requested or may have used this product to vaccinate adults whom they had originally planned to vaccinate with the Chiron product, either of which could have decreased the amount of vaccine available in these practices for use in young children.
